title: [Bilio-intestinal bypass in the treatment of metabolic syndrome in obese patient].
abstract: BACKGROUND
  obesity (O) is a chronic patologic condition, evolutive and relapsing, with multifactorial etiopathogenesis, consisting in an alteration of the body's composition characterized by a relative and absolute excess of fat, that gets worse the life quality and causes complications that can lead to death.
  
  
  METHODS
  experience concerns twenty-five diabetic obese patients underwent bilio-intestinal by-pass between January 2006-December 2007. All these patients, before the surgical operation, underwent a rigorous clinical and laboratory examination. Besides, a precise rate control of laboratory, overlap with those performed in the pre-operative period of operation, was required for each patient: the first after one month, the second after six months and the third after twelve months.
  
  
  RESULTS
  the average weight loss was about 40 kg and, more important, these data show that the BMI is reduced, until to become stable, after 12 months from surgical operation, about values 34-31 Kg/m², obtaining, in this way, an improvement of values in the development metabolic syndrome and, above all, heart rate and ventricular repolarization.
  
  
  CONCLUSIONS
  the data obtained by our study support the hypothesis to suggest the operations of bariatric malassorbing surgery, in particular bilio-intestinal by-pass, as prophylactic methods for dismetabolics diseases, with reduction of cardiovascular risk in obese patient.
authors.affiliation: Seconda Università Degli Studi di Napoli.
authors.forename: R
authors.initials: R
authors.lastname: Ruggiero
authors.forename: G
authors.initials: G
authors.lastname: Docimo
authors.forename: V
authors.initials: V
authors.lastname: Russo
authors.forename: L
authors.initials: L
authors.lastname: Sparavigna
authors.forename: I
authors.initials: I
authors.lastname: Verde
authors.forename: P
authors.initials: P
authors.lastname: Capuano
authors.forename: A
authors.initials: A
authors.lastname: Topatino
authors.forename: S
authors.initials: S
authors.lastname: Gili
authors.forename: V
authors.initials: V
authors.lastname: Amoroso
authors.forename: A L
authors.initials: AL
authors.lastname: Mozzillo
authors.forename: E
authors.initials: E
authors.lastname: Iovinella
authors.forename: R
authors.initials: R
authors.lastname: D'Anna
authors.forename: A
authors.initials: A
authors.lastname: Bosco
authors.forename: L
authors.initials: L
authors.lastname: Docimo
mesh_terms: D000328:Adult; D015904:Biliopancreatic Diversion / Q000379:methods*; D015992:Body Mass Index; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007581:Jejunoileal Bypass / Q000379:methods*; D010535:Laparoscopy / Q000379:methods; D008297:Male; D024821:Metabolic Syndrome / Q000601:surgery*; D008875:Middle Aged; D009767:Obesity, Morbid / Q000601:surgery*; D011788:Quality of Life; D012189:Retrospective Studies; D016896:Treatment Outcome; D015431:Weight Loss